| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |